user

Antiplatelet medications in the secondary prevention of ischemic stroke

被引：0
|
作者：
James D. Fleck
机构：
[1] Indiana University School of Medicine,Department of Neurology
来源：
Current Neurology and Neuroscience Reports | 2005年 / 5卷 / 1期
关键词：
Aspirin; Clopidogrel; Dipyridamole; Ticlopidine; Telmisartan;
D O I：
10.1007/s11910-005-0015-2
中图分类号：
学科分类号：
摘要：
It is difficult to make general statements regarding choices in the medical management of patients with IS given its multiple mechanisms and individual patient variations. It is exceedingly important to manage all vascular risk factors in each patient, especially hypertension. Managing risk factors is as important as, or perhaps more important than, deciding on a prevention medication. Based on the previous discussion, I present my recommendations for antiplatelet secondary prevention of noncardioembolic IS.
引用
收藏
页码：1 / 3
页数：2
相关论文
共 50 条
  • [31] Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis
    Wang, Wen
    Zhang, Lu
    Liu, Weiming
    Zhu, Qin
    Lan, Qing
    Zhao, Jizong
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05): : 1081 - 1089
  • [32] Secondary Ischemic Stroke Prevention
    Aaron Bangad
    Mehdi Abbasi
    Adam de Havenon
    [J]. Neurotherapeutics, 2023, 20 : 721 - 731
  • [33] Secondary prevention of ischemic stroke
    Rantanen, K
    Tatlisumak, T
    [J]. CURRENT DRUG TARGETS, 2004, 5 (05) : 457 - 472
  • [34] Secondary Ischemic Stroke Prevention
    Bangad, Aaron
    Abbasi, Mehdi
    de Havenon, Adam
    [J]. NEUROTHERAPEUTICS, 2023, 20 (03) : 721 - 731
  • [35] Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study
    Andrea Gallo
    Silvia Galliazzo
    Stefano Grazioli
    Luigina Guasti
    Walter Ageno
    Alessandro Squizzato
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 336 - 344
  • [36] The Use of Antiplatelet Agents for Secondary Prevention of Ischemic Stroke in US Ambulatory Care Settings
    Niska, Richard
    Han, Beth
    [J]. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2009, 20 (03) : 831 - 839
  • [37] Topic: AS23 Stroke Prevention (primary and secondary) OPTIMAL ANTIPLATELET THERAPY FOR SECONDARY PREVENTION OF ISCHEMIC STROKE IN PATIENTS WHILE ON THE SINGLE ANTIPLATELET AGENT BASED ON LINKED DATA
    Kim, T. J.
    Lee, J. S.
    Yoon, J. S.
    Ko, S. -B.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 37 - 37
  • [38] Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study
    Gallo, Andrea
    Galliazzo, Silvia
    Grazioli, Stefano
    Guasti, Luigina
    Ageno, Walter
    Squizzato, Alessandro
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 336 - 344
  • [39] Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications
    Su, Ya
    Cheng, Xin
    Dong, Qiang
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (11) : 870 - 876
  • [40] Antiplatelet Strategies for Secondary Prevention of Stroke and TIA
    Ishida, Koto
    Messe, Steven R.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (11)
12345